Y-mAbs Therapeutics Inc. filed SEC Form 8-K Leadership Update, Regulation FD Disclosure, Financial Statements ... - Quantisnow

YMAB Stock  USD 4.85  0.34  6.55%   
About 80 percent of Y MAbs' investors are selling. The analysis of the overall investor sentiment regarding Y mAbs Therapeutics suggests that quite a large number of traders are terrified. The current market sentiment, together with Y MAbs' historical and current headlines, can help investors time the market. In addition, many technical investors use Y mAbs Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Y-mAbs Therapeutics Inc. filed SEC Form 8-K Leadership Update, Regulation FD Disclosure, Financial Statements ... Quantisnow

Read at news.google.com
Google News at Macroaxis
  

Y mAbs Therapeutics Current Investor Sentiment

Comfort Level 20

 Terrified

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Y MAbs' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Y mAbs Therapeutics.

Y MAbs Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Y MAbs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Y MAbs Fundamental Analysis

We analyze Y MAbs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Y MAbs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Y MAbs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Earnings To Growth

Price To Earnings To Growth Comparative Analysis

Y MAbs is currently under evaluation in price to earnings to growth category among its peers. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.

Y mAbs Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Y MAbs stock to make a market-neutral strategy. Peer analysis of Y MAbs could also be used in its relative valuation, which is a method of valuing Y MAbs by comparing valuation metrics with similar companies.

Peers

Y MAbs Related Equities

ARQTArcutis Biotherapeutics   7.64   
0%
75.0%
MRSNMersana Therapeutics   6.79   
0%
67.0%
LRMRLarimar Therapeutics   4.91   
0%
48.0%
ERASErasca   0.78   
0%
7.0%
GBIOGeneration Bio   0.78   
0%
7.0%
BLUEBluebird Bio   0.52   
0%
5.0%
MIRMMirum Pharmaceuticals   0.74   
7.0%
0%
TVTXTravere Therapeutics   0.81   
8.0%
0%
KRONKronos Bio   1.09   
10.0%
0%
RVMDRevolution Medicines   1.77   
17.0%
0%
PCVXVaxcyte   1.82   
18.0%
0%
MRUSMerus BV   2.66   
26.0%
0%
CCCCC4 Therapeutics   3.33   
33.0%
0%
EWTXEdgewise Therapeutics   4.03   
40.0%
0%
BDTXBlack Diamond   4.71   
46.0%
0%
DAWNDay One   4.97   
49.0%
0%
PASGPassage Bio   5.65   
56.0%
0%
ZNTLZentalis Pharmaceuticals   7.25   
72.0%
0%
SNDXSyndax Pharmaceuticals   7.56   
75.0%
0%
STROSutro Biopharma   10.06   
100.0%
0%

Complementary Tools for YMAB Stock analysis

When running Y MAbs' price analysis, check to measure Y MAbs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Y MAbs is operating at the current time. Most of Y MAbs' value examination focuses on studying past and present price action to predict the probability of Y MAbs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Y MAbs' price. Additionally, you may evaluate how the addition of Y MAbs to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins